August 2020
27 28 29 30 31 01 02
03 04 05 06 07 08 09
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31 01 02 03 04 05 06

August 23 - 27, 2020
San Francisco, California

ACS organizes two national meetings & expositions each year, and each one attracts an estimated 11,000 to 13,000 chemists, chemical engineers, academicians, graduate and undergraduate students, and other related professionals. During the meeting, scientists present new multidisciplinary research, hear the latest information in their areas of professional interest, and network with colleagues. Programming is planned by our 33 technical divisions that cover all scientific fields, secretariats that focus on multidisciplinary programming, and ACS committees. Each meeting will feature more than 7,000 presentations organized into technical symposia that highlight important research advances with over 250 exhibitors showcasing new technological developments.

Contact person: Vanessa L. Johnson-Evans

September 2020
date and venue to be confirmed
Organised by:
  • Organic and Medicinal Chemistry Division (OMCD) of the Hungarian Chemical Society (HCS) (Hungary)

September 2-5, 2020
Heidelberg, Germany

The conference sets the stage for the dissemination and exchange of new developments in diverse, hot fields within chemical biology, being the platform for inspiration, collaboration and networking for researchers in academia and industry. It is the largest, and longest standing conference in the field, giving over 300 participants multiple opportunities to actively participate. The aim is to provide the possibility for every chemical biologist to meet and discuss with peers, from tool development to biological applications, from computational drug design to synthetic chemistry. Most importantly, participants come to see where the field stands in its full breadth.

Session Topics:

  • Drug and target discovery
  • Glyco- and phospho- chemical biology
  • Chemical optogenetics
  • Origin of life
  • Sensing and probes
  • Protein modifications
  • Cellular reprogramming and synthetic biology
Dedaline for abstract submission is June 15, 2020.

Deadline for registration is July 16, 2020.

For more information please contact: 

EFMC Symposium

September 7-8, 2020

Due to the coronavirus pandemic, the XXVI EFMC International Symposium on Medicinal Chemistry in Basel has been postponed to August 29 - September 2, 2021.

2-days Virtual Event will take place on September 7-8, 2020Two online Sessions will focus on First Time Disclosures & Late Breaking News. Cutting-edge science will be presented by 9 invited speakers giving you the opportunity to learn about the latest developments while safely remaining at home.

Have a look at the Programme here!

EFMC Symposium

September 10-11, 2020

We had originally intended to postpone the 7th meeting by one year and to run it together with the 8th edition at the same location (F. Hoffman-La-Roche site in Basel) on September 2-3, 2021.

However, because we believe this event is important for our community, we have decided to run the 7th EFMC Young Medicinal Chemists' Symposium as a virtual event this year on the original dates of 10th and 11th September 2020

The programme of this virtual event will include:

  • Keynote lectures by 
    • Prof. Pablo Rivera Fuentes (EPF LAUSANNE, Switzerland)
    • Prof. Angela Russell (UNIVERSITY OF OXFORD, United Kingdom)
  • 12 Oral Communications by invited prize winners from national young medicinal chemist meetings in Europe
  • Soft-skills trainings given by the EFMC-YSN (Young Scientists Network) 
We hope to see you all very soon – at least virtually!

September 14-15, 2020
Leiden, The Netherlands

At FIGON (the integrative platform for innovative drug research in the Netherlands) they highly value good connections between industry, academia and government. Strong interactions between these stakeholders will increase the societal impact of Dutch drug research. DMD is the conference where all parties involved in drug research in the Netherlands present their findings, share new scientific content and strengthen their networks.

This year’s theme is t.b.d. Many new developments are influencing innovation in our field. Big data and artificial intelligence (AI) open new doors in all stages from drug discovery to clinical practice. Other developments, such as options to intervene at the RNA level, quicker ways to screen promising small molecules, and the pressing need for new antibiotics all speed up innovation. These are exciting times in pharmaceutical sciences. Bringing together all bright minds in this field in the Netherlands – established as well as young researchers – the DMD will create momentum for innovation.

Attending the Dutch Medicines Days preparatory meetings with representatives of all FIGON member organisations is always a pleasure. Brainstorm sessions bring together people from many different backgrounds. The programme development process leads to new and sometimes unexpected collaborations.

Deadline for abstract submission is July 4, 2020.

For more information please contact: i.dijkgraaf@maastrichtuniversity.nl

Organised by:
  • Division Medicinal Chemistry & Chemical Biology, Royal Netherlands Chemical Society (KNCV-MCCB) (The Netherlands)

September 16-18, 2020
Charles University, Faculty of Pharmacy in Hradec Králové, Czech Republic

Contact person:
Name: Prof. Pharm Dr. Martin Doležal, Ph.D.
Tel: +420 495 067 389
Email: dolezalm@faf.cuni.cz

Organised by:
  • Section of Synthetic Drug of the Czech Pharmaceutical Society (Czech Republic)

September 17-20, 2020
Lviv, Ukraine

For more information contact: ptchm@ptchm.pl

Organised by:
  • Polish Society of Medicinal Chemistry (Poland)

EFMC Sponsored Event

September 21-23, 2020
Verona, Italy

The key role of G protein-coupled receptors (GPCRs) in human disease underpins their importance to modern medicine. We are pleased to announce that Evotec, Italy will support the eighth meeting in this series on GPCR drug discovery, which will combine cutting edge medicinal chemistry with innovative structural biology and novel drug design approaches.

Deadline for abstract submission for oral communication is January 13, 2020.

Deadline for abstract submission for poster presentation is July 22, 2020.

Bursary application deadline is August 7, 2020.

For more information please contact: 

Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)

EFMC Sponsored Event

September 20-24, 2020
Barcelona, Spain

EuroQSAR Symposia are taking place since 1973 and constitute major scientific events in the field of computational drug design, with further applications in agricultural and environmental sciences.

The program will include the following sessions:

  • QSAR without Borders
  • Artificial Intelligence in Drug Design
  • Molecular Dynamics and Kinetics
  • Chemical Space Annotation and Expansion
  • Modelling Drug Safety
  • Challenges in GPCR Drug Design
  • Modelling Drug Transport Mechanisms
  • Predicting Off-Target Pharmacology
  • Network Medicine
  • New Modes of Target Interaction
  • New Trends in Quantum Mechanics
  • Future Challenges Ahead

The 23rd EuroQSAR Symposium, entitled “Integrative Data-Intensive Approaches to Drug Design”, is organised on behalf of QCMS and is chaired by Jordi Mestres (IMIM Hospital del Mar Medical Research Institute).

Deadline for early bird registration and abstract submission for Oral Communications: June 11, 2020

Deadline for abstract submission for Poster Presentation: Auguste 4, 2020

For more information contact: 

October 5-7, 2020
Montpellier, France

The registration is now open for the conference “Cell-penetrating peptides: Next generation delivery systems” which is co-organized with the French Peptides and Proteins Group (GFPP).

This 3-days international symposium will focus on:

• Design and synthesis of CPPs, peptide-based nanoparticles, and other peptide-based delivery systems
• Biophysical, biochemical and/or cell biology approaches to study their interaction with model and/or biological membranes
• In vivo studies and therapeutic/clinical applications of peptide-based delivery systems

This scientific meeting is the continuation of conferences that have lasted for almost ten years, such as the meetings held in Tallinn (May 2011), Paris (July 2015) and Tartu (August 2018).

October 17-21, 2020
Vienna, Austria

This year, the EANM congress will once again provide a full program dedicated to technologists. The focus will be on topics that are important for current practice in the nuclear medicine field, a sector in which scientific and technological advancements have been great. A wide range of subjects will be covered during the Congress. These will include quality control and calibration of instrumentation for imaging and dosimetry, updates in pediatric and neuroendocrine tumor imaging and topics such as departmental organization and advanced competencies.

As in previous years, the chosen topics will be addressed in seven Continuous Technologist Education (CTE) sessions and three mini-courses (MC), during which specialists will share their expertise and knowledge with the audience. There will be the opportunity for debate and active participation through the creation of special interactive sessions.

The deadline for abstract submission is April 25, 2020

Early Bird registrations until July 10, 2020

For more information please contact: 

EFMC Short Course

October 18-21, 2020
Oegstgeest (near Leiden), The Netherlands

This intensive course is intended for scientists working in the field, and the presentations will be given by senior scientists from industry and academia. The number of participants is limited to 35, to allow in depth discussion. Should the number of applications exceed the maximum, preference will be given to applicants from EFMC adhering countries and employees of EFMC corporate members. Upon special request to the organisers, only based on financial conditions and supported by an argued recommendation of the head of the department of the applicant, up to 3 applicants from academia may be admitted at a reduced fee.

Course Outline

G-protein coupled receptors represent the largest class of drug targets. Although they serve as targets for about 30% of the known drugs, many of them is still orphan. In the last 15 years, however, we witnessed dramatic developments in the structural biology and pharmacology of GPCRs. High resolution X-ray and cryo-EM structures made the design of the GPCR ligands more rational. The widening knowledge on their signalling resulted in new concepts such as allosteric modulation, GPCR residence time and biased signalling currently tested in clinical trials. This course will provide an introduction for medicinal chemists to this important target class including concepts and methods applied in the structural biology, modelling, systems biology, pharmacology and medicinal chemistry of GPCRs.  The course will finish with a series of medicinal chemistry case studies, including the discovery of molecular probes, tool compounds, clinical candidates and marketed drugs.

Course Organisers

György Miklós KESERÜ (Research Centre for Natural Sciences, Hungarian Academy of Sciences, Hungary)
Rob LEURS (VU University Amsterdam, The Netherlands)

Local Organisers
Henk TIMMERMAN (VU University Amsterdam, The Netherlands)
Laura HEITMAN (University of Leiden, The Netherlands)

October 22-23, 2020
Albacete, Spain

The Spanish Society of Medicinal Chemistry (SEQT) has the pleasure to invite you to join the XIII SEQT Symposium, scheduled to be held on October 22-23, 2020 at Faculty of Pharmacy facilities in Albacete (Spain). This event will be an excellent opportunity to merge together highly experienced senior scientists from Spain and other European countries, imparting invited and plenary lectures, with students (post-graduated and postdoctoral) and junior researchers. As in previous editions, attendees will have the opportunity to access the latest advances and trends in drug discovery from both an academy and industry perspective.

For more inforation contact: 

Organised by:
  • Sociedad Española de Química Terapéutica (Spain)

EFMC Sponsored Event

October 26-27, 2020
Eindhoven, The Netherlands

The Conference topics will include:

  • G-protein coupled receptors
  • Protein-protein interactions
  • Activity-based protein profiling
  • Carbohydrates/glycans
  • Cellular chemistry
  • Bioorthogonal and bioconjugation chemistry
  • Fragment-based drug design
  • Photopharmacology
Organised by:
  • Division Medicinal Chemistry & Chemical Biology, Royal Netherlands Chemical Society (KNCV-MCCB) (The Netherlands)

EFMC Sponsored Event

November 5-7, 2020
Athens, Greece

18th Hellenic Symposium on Medicinal Chemistry (HSMC-18) is organized by the Hellenic Society of Medicinal Chemistry (HSMC).

It continues the tradition of biannual meetings established since 35 years in Greece as a forum for the discussion of recent advances in medicinal chemistry. The topics include drug design and lead identification and optimization, protein-protein interactions and protein degradation, ADME/Tox properties, advances in Synthetic Medicinal Chemistry, Natural Products, Pharmacology as well as the impact of artificial intelligence in the integration of data-intensive practices to Drug Discovery. 

For more information please contact: s.si@zita-congress.gr

Organised by:
  • Hellenic Society of Medicinal Chemistry (Greece)

November 10-13, 2020
Atlanta, United States

To promote research, education, and translational impact at the interface of chemistry and biology, ICBS2020 will bring together students, scientists, educators, publishers, and other interested participants across academia, industry, government, and non-profit organizations around the world. As innovative chemistry, novel technologies, and conceptual advances in chemical biology are transforming the landscape of life sciences and health industry, it is timely for chemical biologists from both academic and industry perspectives to highlight new discoveries and breakthroughs, discuss opportunities and challenges, and identify emerging concepts and synergisms. To maximize active interactions, ICBS2020 will feature thought leaders for keynote and plenary lectures, Rising Stars, focused sessions on specialized topics, students and postdoc-oriented Young Chemical Biologist Forum, and podium flash presentations. 

For more information please contact Dr Tiffany Bell-Horwath at

December 2020
The Netherlands
Organised by:
  • Division Medicinal Chemistry & Chemical Biology, Royal Netherlands Chemical Society (KNCV-MCCB) (The Netherlands)

March 21-25, 2021
San Antonio, Texas

EFMC Sponsored Event

April 2021
London, United Kingdom

Cell surface transporters play a key role in human health and disease, both through their impact on drug disposition and as therapeutic targets in their own right. This third meeting in the series will feature talks on transporter structural biology, the impact of transporters on ADME and biodistribution, transporters as therapeutic targets and other aspects of transporters relevant to drug discovery and development. 

For more information please contact: 

Organised by:

SCI's Fine Chemicals Group, RSC’s Biological and Medicinal Chemistry Sector (BMCS) and the Drug Metabolism Discussion Group (DMDG)

EFMC Sponsored Event

May 4-5, 2021
Liverpool, United Kingdom

Members from across the DMPK research community are encouraged to join colleagues from across academic, industrial, and third-sector institutions and contribute to the ongoing discussion, evolution and application of DMPK in various scenarios.

The event programme will incorporate sessions themed around the following key topics:
- DMPK and Drug Discovery
- DMPK and Drug Safety
- Analytical and Computational Advances in DMPK

In addition, the programme also includes a keynote talk, ‘flash’ presentations from early career researchers, and opportunities for open debate and discussion.

For more information please contact: 

Organised by:
  • The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC) (United Kingdom)

June 9-11, 2021
Kuopio, Finland

The Chemical Sciences in Biological Challenges combines life and health sciences with bio- and natural sciences. In the conference chemical sciences meet the challenges of biological environments from the perspective of drug development, environmental sciences as well as circular economy. The Key note lecturers are the top scientists on the fields of various disciplines, e.g. NMR spectroscopy, pharmacology, medicinal chemistry, organic synthesis, peptide research etc.

For more information please contact: 

Organised by:
  • Finnish Pharmaceutical Society (Finland)

June 16-18, 2021

June 27-July 1, 2021
Urbino, Italy

ESMEC 2021 is special, celebrating the 40th edition!

The mission of the ESMEC is to provide participants, PhD students and junior researchers from both academia and industry, with the most recent advances in the field of medicinal and organic chemistry, pharmacology, molecular biology and analytical/ structural chemistry. This idea is aimed to reflect the current scenario of medicinal chemistry being a truly transdisciplinary approach, where the advances in knowledge are driven by the medicinal chemist’s ability to translate into new molecular concepts and into novel molecular entities the amount of information created by molecular medicine, pharmacology, molecular biology, systems biology.

This year the scientific programme includes the following topics:

  • Proteolysis Targeting Chimera (Protac): From Medicinal Chemistry to Clinical Trials
  • Sustainable Chemistry Approaches To Lead Discovery and Chemical Processes
  • Medicinal Chemistry’s Response To the Burden of Antibiotic Resistance
  • Market Watch: New Drug Approval in 2019 and Synthetic Strategies

ESMEC Alumni Award

The ESMEC Alumni Award will be given to an outstanding European researcher in the field of Medicinal Chemistry who has participated in the school either as an oral or poster presenter.
The prize consists of a diploma, a medal and an invitation to give a presentation at ESMEC 2021.

For more information visit: www.esmec.eu

Organised by:
  • Division of Medicinal Chemistry of the Italian Chemical Society (Divisione di Chimica Farmaceutica - Società Chimica Italiana, DCF-SCI) (Italy)

June 27-30, 2021
Vilnius, Lithuania

BOS 2021, Vilnius constitutes the 11th biennial international conference on organic synthesis. The BOS conference main aims have remained unchanged during this long eighteen years history:

  • to convey the excitement of synthetic organic chemistry as practiced in industry and universities worldwide;
  • to promote interactions between chemists of different countries in order to create links, collaborations, common research projects in both, academic and industrial settings.


  • Invited lectures by a distinguished roster of Baltic and international speakers.
  • A balanced program of academic and industrial speakers presenting fundamental and practical aspects of organic synthesis.
  • Poster sessions held in a congenial atmosphere to stimulate discussion.
  • A full social programme with a reception, final banquet and city tours.
For more information please contact: 

June 27-30, 2021
New York City, United States

The American Chemical Society, Division of Medicinal Chemistry, is glad to invite you to New York City from Sunday, June 27 to Wednesday, June 30, 2021, for the 37th edition of the National Medicinal Chemistry Symposium.

As per its tradition, this dynamic four day symposium aims to bring together medicinal chemists from across the country working in the pharmaceutical industry, academia, government and private research institutions.

Attendees will be updated on the emerging techniques and applications within the field, and are encouraged to submit abstracts to share their ideas and results. Several poster prizes will be awarded during the meeting.

The Program of the 37th NMCS will include the following Sessions:

  • Integrating Novel Chemical Modalities in Hit-to-lead: a New Paradigm for Early Drug Discovery
    Chair: Maria-Jesus Blanco (SAGE Therapeutics)

  • New Directions in Targeting DNA Damage Repair (DDR)
    Chairs: Erin DiMauro (Merck & Co. Inc.) and Srinivasa Karra (Alkermes, Inc.)

  • Hot Targets from NYC Academic and Biotech Scene
    Chairs: Robert DeVita (Icahn School of Medicine at Mt Sinai) and Amjad Ali (Merck & Co. Inc.)

  • Targeting Autophagy for Cancer, Neurodegeneration, or Autoimmune Disease
    Chairs: Erin DiMauro (Merck & Co. Inc.) and Hongjun Zhang (Merck & Co. Inc.)

  • “If At First You Don’t Succeed, Try, Try, Try Again”: How Clinical Failures Propelled Next Generation Candidates
    Chair: Matthew Volgraf (Genentech Inc.)

  • Lessons from Drug Hunters across Academia, NPOs and the Pharmaceutical Industry
    Chair: Phil Kym (AbbVie)

In addition, the Program will also feature an Award Session.

For more information please contact:

August 22-26, 2021
Atlanta, Georgia

EFMC Symposium

August 29 - September 2, 2021
Basel, Switzerland
Organised by:
  • Division for Medicinal Chemistry & Chemical Biology (DMCCB) (Switzerland)
  • European Federation of Medecinal Chemistry (EFMC)

EFMC Symposium

September 2-3, 2021
Basel, Switzerland
Organised by:
  • Division for Medicinal Chemistry & Chemical Biology (DMCCB) (Switzerland)
  • European Federation of Medecinal Chemistry (EFMC)

September 26-29, 2021

October 3-8 2020
Leysin, Switzerland

This five-day Medicinal Chemistry School that is organized by the Division of Medicinal Chemistry and Chemical Biology of the Swiss Chemical Society will focus on most modern aspects associated with small molecule drug discovery, highlighting the methodologies and technologies supporting hit generation, lead finding and lead optimization campaigns.

In the beautiful and scenic village of Leysin, close to Lake Geneva, more than 100 young scientists are expected to meet with app. 35 international renowned expert speakers and instructors.

As in previous years, the teaching content will be targeted at young scientists working in the area of medicinal chemistry, but also from flanking disciplines such as biochemistrypharmacypharmacology, or biophysics from the pharmaceutical and biotech industry. Given the broad spectrum and the timeliness of scientific topics discussed, the course also provides a valuable opportunity for advanced medicinal chemists to get acquainted with most recent developments in e.g. the medicinal chemistry of novel target families, novel compound classes, and most modern optimization paradigms. In addition, a number of PhD students and postdocs will be able to attend to receive a broad overview on scientific disciplines involved in modern drug discovery.

The upcoming event will thematically be structured along key topics of strategic relevance for medicinal chemistry that will be presented by opinion leaders in the field. The teaching content will further be intensified by hands-on tutorials in which the theoretical learning’s can immediately be applied to real life problems of pre-clinical drug discovery.

Organised by:
  • Division for Medicinal Chemistry & Chemical Biology (DMCCB) (Switzerland)

March 20-24, 2022
San Diego, California

August 21-25, 2022
Chicago, Illinois

EFMC Symposium

September 4-8, 2022
Nice, France
Organised by:
  • Société de Chimie Thérapeutique (France)
  • European Federation of Medecinal Chemistry (EFMC)

March 26-30, 2023
Indianapolis, Indiana

August 13-17, 2023
San Francisco, California

EFMC Symposium

September 3-7, 2023
Zagreb, Croatia

Symposium Chairs: 

  • Prof. Karl Gademann, Universirty of Zurich, Switzerland
  • Dr Ingo Hartung, Merck, Germany 
Organised by:
  • Croatian Chemical Society, Section of Medicinal/Pharmaceutical Chemistry (Croatia)
  • European Federation of Medecinal Chemistry (EFMC)

March 17-21, 2024
New Orleans, Louisianna

August 18-24, 2024
Denver, Colorado

EFMC Symposium

September 1-5, 2024
Rome, Italy
Organised by:
  • Division of Medicinal Chemistry of the Italian Chemical Society (Divisione di Chimica Farmaceutica - Società Chimica Italiana, DCF-SCI) (Italy)
  • European Federation of Medecinal Chemistry (EFMC)

March 23-27, 2025
San Diego, California

August 17-21, 2025
Washington, District of Columbia